Detection of Esophageal Varices Using CT and MRI

Size: px
Start display at page:

Download "Detection of Esophageal Varices Using CT and MRI"

Transcription

1 Dig Dis Sci (2011) 56: DOI /s ORIGINAL ARTICLE Detection of Esophageal Varices Using CT and MRI Michael J. Lipp Arkady Broder David Hudesman Pauline Suwandhi Steven A. Okon Mitchell Horowitz David J. Clain Patricia Friedmann Albert D. Min Received: 9 November 2010 / Accepted: 22 February 2011 / Published online: 6 March 2011 Ó Springer Science+Business Media, LLC 2011 Abstract Background and Aims The development of esophageal varices in cirrhotic patients carries a significant risk of hemorrhage and associated morbidity/mortality. Universal endoscopic screening, however, is invasive and expensive. Conversely, cirrhotic patients often have imaging findings which suggest portal hypertension. The aim of this study was to evaluate the ability of CT and/or MRI to detect esophageal varices compared to EGD. Methods Medical records from 2000 to 2007 were retrospectively reviewed. CT and/or MRI images were included if performed within 90 days of EGD. Two blinded, experienced radiologists were asked to review images for the presence of esophageal varices, as well as other findings associated with portal hypertension. Sensitivity, specificity, PPV and NPV were calculated using EGD findings as the gold standard. Results A total of 195 patients and 142 patients met criteria for CT and MRI, respectively. The sensitivity of CT to detect EGD varices was 58 89%, but increased to % when specifically looking at large endoscopic varices. Overall specificity was 68 82%, but increased to % when applying C4 mm varices criteria. CT was M. J. Lipp (&) D. Hudesman D. J. Clain P. Friedmann A. D. Min Division of Digestive Diseases, Beth Israel Medical Center, First Avenue at 16th Street, 17-BH, New York, NY 10003, USA lipp50@gmail.com A. Broder P. Suwandhi Department of Medicine, Beth Israel Medical Center, New York, NY, USA S. A. Okon M. Horowitz Department of Radiology, Beth Israel Medical Center, New York, NY, USA superior to MRI in the detection of endoscopic varices; the addition of other portal hypertension stigmata did not improve results. Conclusions The exclusion of large endoscopic varices by CT, using standardized criteria, may obviate the need or frequency of EGD screening in select patient populations. Alternatively, CT findings highly suggestive of esophageal varices in cirrhotic patients may warrant further investigation and/or treatment. Further studies are needed to validate these findings. Keywords Esophageal varices Computerized tomography Magnetic resonance imaging Noninvasive Introduction The progression to cirrhosis is often accompanied by the development of portal hypertension, as an increase in portal pressure leads to the development of porto-systemic collaterals. Esophageal varices are perhaps the most clinically relevant porto-systemic collaterals. Because of their possible rupture and hemorrhage, esophageal varices remain the most common lethal complication of portal hypertension with a reported mortality rate as high as 20 30% at 6 weeks [1, 2]. The presence of gastroesophageal varices correlates with the Child-Turcotte-Pugh class, and ranges from 40 to 85% of patients with the highest rates in Child- Pugh class C cirrhotics [3]. Size is the most important predictor of variceal hemorrhage with large varices conferring the highest yearly risk of first hemorrhage in as many as 15% of patients [4] and a rebleeding risk (within 1 2 years) of 60% in previously untreated patients [5]. The gold standard in diagnosis of esophageal varices remains esophagogastroduodenoscopy (EGD). Variceal

2 Dig Dis Sci (2011) 56: size is an important predictor of bleeding risk and should be quantified as either small or large, with a recommended cut-off diameter of 5 mm or the older morphological description of 2? or greater [6, 7]. EGD is recommended once the diagnosis of liver cirrhosis is established, with follow-up surveillance intervals ranging from 1 to 3 years, with the most frequent yearly follow-up recommended in patients with decompensated cirrhosis [8]. Invasive endoscopic examination, however, carries with it high costs and multiple procedure related risks, which are often augmented in patients with decompensated cirrhosis [9]. Therefore, there has been substantial interest in developing a reliable non-invasive method of accurately predicting the degree of cirrhosis and portal hypertension size such as the platelet count, spleen size, Fibrotest, Fibroscan, portal vein diameter, transient elastography and esophageal capsule endoscopy [10]. However, to date the predictive value of these markers remains unclear, with low sensitivities that often result in failure to identify large varices [6]. The presences of esophageal varices, or other findings associated with portal hypertension, are often found when dedicated liver CT and/or MRI are performed on cirrhotic patients for cancer screening or diagnostic indication [11, 12]. The clinical significance of these findings, however, is uncertain, in part because of the absence of insufflation during these studies compared to endoscopy. There have been several recent studies proposing CT and MRI imaging modalities as an alternative means of diagnosing esophageal varices [13 15]. The study by Kim et al. developed radiologic criteria, and concluded that a 3-mm screening threshold on CT was optimal for sensitivity, specificity, and accuracy. A study by Perri et al. used a CT cutoff of 5 mm, and concluded that CT could be a cost-effective screening test for esophageal varices. One of the critiques of this study, however, was that using CT as a primary screening modality would result in patients with large varices being misdiagnosed [16]. The aim of our study was to retrospectively evaluate the effectiveness of CT and/or MRI imaging modalities to detect esophageal varices, when compared to gold standard EGD findings in cirrhotic patients who had imaging performed for other indications. Methods Patients who presented to our medical center between the years of 2000 and 2007 were retrospectively evaluated. We included all patients 18 years and older who had undergone EGD, abdominal computed tomography (CT) with IV contrast and/or magnetic resonance imaging (MRI) with IV contrast. Imaging studies were included if performed within 90 days of EGD. All EGDs were performed for variceal surveillance in cirrhotic patients by at least one experienced endoscopist. The retrospective nature of our study created a scenario where several cut-offs were used to identify esophageal varix size. Investigators performing EGD classified varices using either the 5-mm cut-off [6], the older 2? numbering system [7], and the currently recommended small, medium and large grading system [6]. A grading of 2? corresponds to being greater than or equal to of the normal esophageal lumen being obstructed by varices. Patients who underwent esophageal banding prior to the obtained imaging were excluded. Patient data regarding age, gender, and date of examination were recorded. Radiologists were blinded to prior EGD reports, the patient mix, and were given a specific protocol to evaluate the findings on CT or MRI. The radiologists had 10 and 20 years of post-training experience, respectively, and were each subspecialists in abdominal imaging. The CT equipment used at our institution during the study period included the General Electric Lightspeed Plus-4 detector row, Siemens Emotion 16, and the Siemens Sensation (64) detector row. Both dedicated multiphase liver protocol and routine single-phase CT studies were included. The MRI equipment used was the General Electric Signa HD 1.5 T MRI unit. MRI images were obtained with multi-phased dynamic enhancement, spoiled gradient, fat saturation, and were T1 weighted. Based on the prior study by Kim et al., which aimed to detect esophageal varices in cirrhotic patients, esophageal varices on imaging were defined as the probable presence of either discrete enhancing nodular lesions abutting the luminal surface of the esophageal wall or protruding into luminal space or ill defined nodular enhancing lesions appeared to be contacting or protruding into the lumen [14]. Based on these criteria, radiologists used a standardized form to evaluate the assigned images for the presence of varices and other stigmata of portal hypertension. Radiologists were initially asked to determine if the assigned imaging provided adequate views for the detection of esophageal varices. Studies lacking adequate views were excluded for each radiologist. Each radiologist determined the presence of esophageal varices and the approximate size by measuring the diameter of the largest observed varix. A quantitative cutoff for large varices seen on CT or MRI was chosen as greater than or equal to 4 mm in diameter based on previous studies [13, 15]. Other stigmata of portal hypertension evaluated included paraesophageal, gastric and perigastric varices, as well as a recanalized peri-umbilical vein and spleno-renal shunt. The primary endpoint of the study was the positive and negative predictive values (PPV and NPV) of CT and MRI in determining the presence of any and/or large esophageal varices. The identity of patients and their medical records were kept confidential, and all study procedures were

3 2698 Dig Dis Sci (2011) 56: compliant with the standards set forth by the institutional review board (IRB). Statistical Analysis Data were analyzed with the SAS system version Descriptive data analyses were conducted. Sensitivity, specificity, positive and negative predictive values of CT with contrast and MRI readings were computed and expressed as percents with 95% confidence intervals. EGD findings were used as the gold standard. Results Two-hundred ninety-nine patients met the inclusion criteria and were included in the data analysis. Baseline characteristics of these patients are described in Table 1. The mean age of the patient population was 55.2, with a male to female distribution 64.9 and 35.1%, respectively. The overall prevalence of esophageal varices on EGD was 41.4% (124/299), with a 20.3% prevalence of large esophageal varices. Table 1 Baseline patient characteristics Baseline characteristics Value (N = 299) Mean age (years) 55.2 ± 10 Mean time EGD to imaging (days) 27.8 ± 24.4 Gender, n (%) Male 194 (64.9%) Female 105 (35.1%) Presence of endoscopic varices, n (% of patients) Large varices 61 (20.3) Small varices 63 (21.1) EGD esophagogastroduodenoscopy Imaging studies were included if views were deemed adequate by the radiologists (Fig. 1). Out of a total of 195 CT images, radiologist 1 included 138 studies (71%), and radiologist 2 included 165 (85%). Of 142 MRI images that met initial study criteria, radiologist 1 included 126 (89%) and radiologist 2 included 93 (66%). A comparison was made of each radiologist s ability to detect the presence of any varices on CT imaging as compared to EGD (Table 2). This revealed a sensitivity of 89 and 58%, respectively, for radiologists 1 and 2. When the 4-mm variceal size criteria was applied to the interpretation of varices seen on CT, a notable result was an increase in the specificity for radiologists 1 and 2, i.e., 97% and 100%, respectively. The 4-mm CT criteria was also associated with an increase in the positive predictive value of any esophageal varices to 93 and 100% for radiologist 1 and 2, respectively. The negative predictive value for anysized esophageal varices was 88% for radiologist 1 and 72% for radiologist 2. Further analysis was performed to evaluate the ability to detect the presence of large esophageal varices noted on EGD (C2?) using CT imaging (Table 3). Notable findings included 100% sensitivity for radiologist 1 when evaluating any for esophageal varices using CT. Radiologist 2 had a lower sensitivity of 65% using similar criteria. These findings were associated with high negative predictive values of 100% for radiologist 1 and 89% for radiologist 2. Thus, a negative CT reading was able to exclude large endoscopic varices in 100% of cases (59/59) for radiologist 1 and 89% of cases for radiologist 2 (95/107). When the 4-mm CT criteria was applied to the interpretation of large EGD varices, the specificity of radiologists 1 and 2 were 90 and 97%, respectively. These findings correlate with modest positive predictive values of 62% for radiologist 1 and 75% for radiologist 2. Data analysis comparing the radiologists ability to detect EGD varices using MRI images was also performed. Overall, the sensitivity and specificity for detecting the presence of any sized varices was poor when compared to Fig. 1 Radiology assessment of adequate CT and MRI images

4 Dig Dis Sci (2011) 56: Table 2 Sensitivity, specificity, PPV, NPV of CT for any EGD varices Criteria Observer 1 Observer 2 Values 95% CI Values 95% CI Sensitivity (%) Any size 89 (54/61) (41/71) Size [4 mm 44 (27/61) (16/71) Specificity (%) Any size 68 (52/76) (77/94) Size [4 mm 97 (74/76) (94/94) Positive predictive value (%) Any size 69 (54/78) (41/58) Size [4 mm 93 (27/29) (16/16) Negative predictive value (%) Any size 88 (52/59) (77/107) Size [4 mm 69 (74/108) (94/149) CI confidence interval, PPV positive predictive value, NPV negative predictive value, CT computed tomography, EGD esophagogastroduodenoscopy Table 3 Sensitivity, specificity, PPV, NPV of CT for large EGD varices Criteria Observer 1 Observer 2 Values 95% CI Values 95% CI Sensitivity (%) Any size 100 (30/30) (22/34) Size [4 mm 60 (18/30) (12/34) Specificity (%) Any size 55 (59/107) (95/131) Size [4 mm 90 (96/107) (127/131) Positive predictive value (%) Any size 38 (30/78) (22/58) Size [4 mm 62 (18/29) (12/16) Negative predictive value (%) Any size 100 (59/59) (95/107) Size [4 mm 89 (96/108) (127/149) CI confidence interval, PPV positive predictive value, NPV negative predictive value, CT computed tomography, EGD esophagogastroduodenoscopy CT (sensitivities for radiologists 1 and 2 were 29 and 29%; specificities were 35 and 33%, respectively). Similarly, the positive and negative predictive values for each radiologist was low (PPV of 35 and 33% for radiologists 1 and 2; NPV 53 and 24%, respectively). The presence of other portal hypertension stigmata were evaluated for both CT and MRI imaging. This included the paraesophageal, gastric and perigastric varices, as well as a recanalized peri-umbilical vein and spleno-renal shunt. The addition of these findings, however, did not improve the ability to predict endoscopic Fig. 2 Computed tomography (CT) axial image of the lower esophagus showing a nodular, enhancing, intraluminally protruding 6-mm lesion within the esophageal wall (arrows) varices when compared to the imaging of esophageal varices alone (data not shown) (Fig. 2). Discussion Our results show the potential of CT imaging to detect and/ or exclude the presence of esophageal varices in patients with cirrhosis. CT imaging had a high positive predictive value for diagnosing any-sized esophageal varices (93 100%), as well as an impressive negative predictive value in ruling out large/clinically significant esophageal varices (89 100%). Additionally, our findings suggest that CT is a superior imaging modality to MRI in the detection of esophageal varices. Furthermore, the evaluation of portal hypertension stigmata on imaging, such as paraesophageal, gastric and perigastric varices, recanalized peri-umbilical vein and spleno-renal shunt, did not improve the predictive value when compared to the presence of esophageal varices alone. Our study has several limitations. There are no standardized radiology criteria to classify esophageal varices, and the criteria used in our study were based on those used by Kim et al. [15]. Thus, the radiologists in this study did not receive formal training in interpretation of varices. Additionally, there was variability in the interpretation of adequate image quality. To mimic clinical practice, radiologists were not asked to interpret images they felt had inadequate image quality. Unfortunately, since each radiologist did not evaluate every imaging study independently regardless of perceived quality, we were unable to determine intraobserver and interobserver variability. It is also important to note that although EGD findings were used as the gold standard, the fact that EGDs were performed by

5 2700 Dig Dis Sci (2011) 56: more that one endoscopist is problematic given the data indicating a lack of agreement between endoscopists in describing varices [17, 18]. Thus, weakness of EGD as a gold-standard for diagnosing esophageal varices is a limitation as well. There may have also been heterogeneity in our patient population, with potential physician bias in determining which patients should have a CT or MRI performed. Also, our database did not include potentially useful patient information such as the presence of portal vein thrombosis and differences between each protocol and type of CT machine. It would have been of interest to determine Childs Pugh scores; however, due to the limitations of a retrospective database we were unable to determine those scores. Finally this was a single center, retrospective study, with uncertain generalizability to other radiologists and patient populations without further studies. Despite these limitations, these results are clinically relevant given the need to develop a sensitive and noninvasive method of accurately predicting the presence of esophageal varices. This study differs from previous trials in that these imaging studies were not performed for the purpose of detecting esophageal varices. The primary indication for the majority of CT and/or MRIs was to evaluate for hepatocellular carcinoma. One potential advantage to evaluating images obtained for another purpose is that patients would not be subjected to additional risks of radiation exposure, and that no additional costs would be incurred. Clinicians would also benefit from understanding how a given radiographic interpretation may change the likelihood of esophageal varices in a given patient with cirrhosis. Thus, the exclusion of large varices by CT findings using standardized size criteria may obviate the need for EGD in select patient populations. Alternatively, CT findings highly suggestive of esophageal varices in cirrhotic patients may warrant further investigation and/ or treatment. In our study we used the radiology criteria developed by Kim et al. [14] using a 4-mm cutoff for large varices. Further studies are needed to test whether these results apply to other institutions, and these standardized criteria may be incorporated into radiology training programs. Given the frequency of CT imaging performed in the care of patients with cirrhosis, however, these findings suggest that there is considerable potential to reduce the costs and/ or frequency of EGD screening in this population. 2. Fontana RJ, Sanyal AJ, Ghany MG, et al. Factors that determine the development and progression of gastroesophageal varices in patients with chronic hepatitis C. Gastroenterology. 2010;138: Pagliaro L, D Amico G, Pasta L. Portal hypertension in cirrhosis: Natural history. In: Bosch J, Groszmann RJ, et al., eds. Portal Hypertension. Pathophysiology and Treatment. Oxford, UK: Blackwell Scientific; 1994: El-Serag HB, Everhart JE. Improved survival after variceal hemorrhage over an 11-year period in the department of veterans affairs. Am J Gastroenterol. 2000;95: Bosch J, Garcia-Pagan JC. Prevention of variceal rebleeding. Lancet. 2003;361: Garcia-Tsao G, Sanyal AJ, Grace ND, et al. Practice Guidelines Committee of the American Association for the Study of Liver Diseases the Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46: Dagradi AE. Endoscopy of oesophageal varices. Gastroenterol Jpn. 1972;7: de Franchis R. Updating consensus in portal hypertension: Report of the Baveno III consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol. 2000;33: Eisen GM, Baron TH, Dominitz JA, et al. Complications of upper GI endoscopy. Gastrointest Endosc. 2002;55: de Franchis R. Non-invasive (and minimally invasive) diagnosis of oesophageal varices. J Hepatol. 2008;49: Andersson KL, Salomon JA, Goldie SJ, et al. Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol. 2008;6: Perri RE, Chiorean MV, Fidler JL, et al. A prospective evaluation of computerized tomographic (CT) scanning as a screening modality for esophageal varices. Hepatology. 2008;47: Kim SH, Kim YJ, Lee JM, et al. Esophageal varices in patients with cirrhosis: Multidetector CT esophagography comparison with endoscopy. Radiology. 2007;242: Kim H, Choi D, Gwak GY, et al. Evaluation of esophageal varices on liver computed tomography: Receiver operating characteristic analyses of the performance of radiologists and endoscopists. J Gastroenterol Hepatol. 2009;24: Kim YJ, Raman SS, Yu NC, et al. Esophageal varices in cirrhotic patients: Evaluation with liver CT. Am J Roentgenol. 2007;188: Thabut D, Moreau R, Lebrec D. Screening for esophageal varices: Endoscopy, other tools, or endoscopy and other tools? Hepatology. 2008;47: Bendtsen F, Skovgaard LT, Sørensen TI, et al. Agreement among multiple observers on endoscopic diagnosis of esophageal varices before bleeding. Hepatology. 1990;11: Cales P, Pascal JP. Gastroesophageal endoscopic features in cirrhosis: Comparison of intracenter and intercenter observer variability. Gastroenterology. 1990;99:1189. Conflict of interest None. References 1. Carbonell N, Pauwels A, Serfaty L, et al. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology. 2004;40:

Multidetector computed tomography versus platelet/spleen diameter ratio as methods for the detection of gastroesophageal varices

Multidetector computed tomography versus platelet/spleen diameter ratio as methods for the detection of gastroesophageal varices ORIGINAL ARTICLE Annals of Gastroenterology (2015) 28, 1-8 Multidetector computed tomography versus platelet/spleen diameter ratio as methods for the detection of gastroesophageal varices Andreas Karatzas

More information

Primary Prophylaxis against Variceal Hemorrhage Pharmacotherapy vs Endoscopic Band Ligation

Primary Prophylaxis against Variceal Hemorrhage Pharmacotherapy vs Endoscopic Band Ligation Primary Prophylaxis against Variceal Hemorrhage Pharmacotherapy vs Endoscopic Band Ligation Siwaporn Chainuvati, MD Faculty of Medicine Siriraj Hospital Outline Natural history of esophageal varices Which

More information

Michele Bettinelli RN CCRN Lahey Health and Medical Center

Michele Bettinelli RN CCRN Lahey Health and Medical Center Michele Bettinelli RN CCRN Lahey Health and Medical Center Differentiate the types of varices Identify glue preparations utilized when treating gastric varices Review the process of glue administration

More information

Title: The Baveno VI criteria for predicting esophageal varices: validation in real life practice

Title: The Baveno VI criteria for predicting esophageal varices: validation in real life practice Title: The Baveno VI criteria for predicting esophageal varices: validation in real life practice Authors: Mafalda Sousa, Sónia Fernandes, Luísa Proença, Ana Paula Silva, Sónia Leite, Joana Silva, Ana

More information

Esophageal Varices Beta-Blockers or Band Ligation. Cesar Yaghi MD Hotel-Dieu de France University Hospital Universite Saint Joseph

Esophageal Varices Beta-Blockers or Band Ligation. Cesar Yaghi MD Hotel-Dieu de France University Hospital Universite Saint Joseph Esophageal Varices Beta-Blockers or Band Ligation Cesar Yaghi MD Hotel-Dieu de France University Hospital Universite Saint Joseph Esophageal Varices Beta-Blockers or Band Ligation? Risk of esophageal variceal

More information

Is pharmacological therapy the best choice for primary prevention of variceal hemmorhaging in patients with hepatic cirrhosis?

Is pharmacological therapy the best choice for primary prevention of variceal hemmorhaging in patients with hepatic cirrhosis? Controversies en Gastroenterology Is pharmacological therapy the best choice for primary prevention of variceal hemmorhaging in patients with hepatic cirrhosis? Rolando José Ortega Quiroz, MD, 1 Adalgiza

More information

ORIGINAL ARTICLES LIVER, PANCREAS, AND BILIARY TRACT

ORIGINAL ARTICLES LIVER, PANCREAS, AND BILIARY TRACT CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2010;8:703 708 ORIGINAL ARTICLES LIVER, PANCREAS, AND BILIARY TRACT Compliance With Practice Guidelines and Risk of a First Esophageal Variceal Hemorrhage in Patients

More information

Gastrointestinal bleeding is one of the most important

Gastrointestinal bleeding is one of the most important Prospective Validation of Baveno V Definitions and Criteria for Failure to Control Bleeding in Portal Hypertension Sun Young Ahn, 1 Soo Young Park, 1 Won Young Tak, 1 Yu Rim Lee, 1 Eun Jeong Kang, 1 Jung

More information

ACG & AASLD Joint Clinical Guideline: Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis

ACG & AASLD Joint Clinical Guideline: Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis ACG & AASLD Joint Clinical Guideline: Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis Guadalupe Garcia-Tsao, M.D., 1 Arun J. Sanyal, M.D., 2 Norman D. Grace,

More information

Evidence-Base Management of Esophageal and Gastric Varices

Evidence-Base Management of Esophageal and Gastric Varices Evidence-Base Management of Esophageal and Gastric Varices Rino Alvani Gani Hepatobiliary Division Department of Internal Medicine Faculty of Medicine Universitas Indonesia Cipto Mangunkusumo National

More information

UNIVERSA MEDICINA. Forns index as a useful noninvasive predictor of esophageal varices in liver cirrhosis

UNIVERSA MEDICINA. Forns index as a useful noninvasive predictor of esophageal varices in liver cirrhosis UNIVERSA MEDICINA September-December, 2016 Vol.35 - No.3 Forns index as a useful noninvasive predictor of esophageal varices in liver cirrhosis Rizqi Arini Siregar*, Leonardo B. Dairi*, and Gontar Alamsyah

More information

ORIGINAL ARTICLES LIVER, PANCREAS AND BILIARY TRACT

ORIGINAL ARTICLES LIVER, PANCREAS AND BILIARY TRACT CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2008;6:1129 1134 ORIGINAL ARTICLES LIVER, PANCREAS AND BILIARY TRACT Spleen Enlargement on Follow-Up Evaluation: A Noninvasive Predictor of Complications of Portal

More information

Risk factors for 5-day bleeding after endoscopic treatments for gastroesophageal varices in liver cirrhosis

Risk factors for 5-day bleeding after endoscopic treatments for gastroesophageal varices in liver cirrhosis Original Article Page 1 of 9 Risk factors for 5-day bleeding after endoscopic treatments for gastroesophageal varices in liver cirrhosis Rui Sun*, Xingshun Qi* #, Deli Zou, Xiaodong Shao, Hongyu Li, Xiaozhong

More information

Evaluation of Clinical, Biochemical and Ultrasound Parameters in Diagnosis of Oesophageal Varices

Evaluation of Clinical, Biochemical and Ultrasound Parameters in Diagnosis of Oesophageal Varices Med. J. Cairo Univ., Vol. 78, No. 2, June: 105-109, 2010 www.medicaljournalofcairouniversity.com Evaluation of Clinical, Biochemical and Ultrasound Parameters in Diagnosis of Oesophageal Varices FAWZY

More information

Screening for Portal Hypertension in Cirrhosis

Screening for Portal Hypertension in Cirrhosis Screening for Portal Hypertension in Cirrhosis MASSIMO PINZANI, MD, PhD, FRCP Sheila Sherlock Chair of Hepatology UCL Institute for Liver and Digestive Health Royal Free Hospital, London, UK m.pinzani@ucl.ac.uk

More information

Are we adequately screening at-risk patients for hepatocellular carcinoma in the outpatient setting?

Are we adequately screening at-risk patients for hepatocellular carcinoma in the outpatient setting? Rajani Sharma, PGY1 Geriatrics CRC Project, 12/19/13 Are we adequately screening at-risk patients for hepatocellular carcinoma in the outpatient setting? A. Study Purpose and Rationale Hepatocellular carcinoma

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Acute variceal bleeding management of, 251 262 balloon tamponade of esophagus in, 257 258 endoscopic therapies in, 255 257. See also Endoscopy,

More information

Variceal bleeding. Mainz,

Variceal bleeding. Mainz, Variceal bleeding Mainz, 21.09.2008 Risk of complications 5 years 10 years Ascites 10 % 25 % HCC 10 % 25 % Bleeding < 5 % 5-10 % Enceph. < 5 % < 5 % Typical situation : Mortality 10 % to 40 % Sequence

More information

Update in abdominal Surgery in cirrhotic patients

Update in abdominal Surgery in cirrhotic patients Update in abdominal Surgery in cirrhotic patients Safi Dokmak HBP department and liver transplantation Beaujon Hospital, Clichy, France Cairo, 5 April 2016 Cirrhosis Prevalence in France (1%)* Patients

More information

th Annual AISF Meeting 44 th th th, 2011 Rome, February 23 rd -26

th Annual AISF Meeting 44 th th th, 2011 Rome, February 23 rd -26 44 th 44 th Annual AISF Meeting Rome, February 23 rd -26 th th, 2011 Update on the Baveno Consensus Conference Roberto de Franchis Department of of Clinical Sciences, University of of Milan, Head, Gastroenterology

More information

The Value of Renal Artery Resistive Indices: Association with

The Value of Renal Artery Resistive Indices: Association with The Value of Renal Artery Resistive Indices: Association with Esophageal Variceal Bleeding in Patients with Alcoholic Cirrhosis 1 Joo Nam Byun, M.D., Dong Hun Kim, M.D. Purpose: To determine whether resistive

More information

Detection of Esophageal Varices in Liver Cirrhosis Using Non-invasive Parameters

Detection of Esophageal Varices in Liver Cirrhosis Using Non-invasive Parameters ORIGINAL ARTICLE Detection of Esophageal Varices in Liver Cirrhosis Using Non-invasive Parameters Johana Prihartini*, LA Lesmana**, Chudahman Manan***, Rino A Gani** ABSTRACT Aim: recent guidelines recommend

More information

Editorial Process: Submission:07/25/2018 Acceptance:10/19/2018

Editorial Process: Submission:07/25/2018 Acceptance:10/19/2018 RESEARCH ARTICLE Editorial Process: Submission:07/25/2018 Acceptance:10/19/2018 Clinical Outcome and Predictive Factors of Variceal Bleeding in Patients with Hepatocellular Carcinoma in Thailand Jitrapa

More information

Diagnostic Procedures. Measurement of Hepatic venous pressure in management of cirrhosis. Clinician s opinion

Diagnostic Procedures. Measurement of Hepatic venous pressure in management of cirrhosis. Clinician s opinion 5 th AISF Post-Meeting Course Diagnostic and Therapeutic Invasive Procedures in Hepatology Rome, February 25 th Diagnostic Procedures Measurement of Hepatic venous pressure in management of cirrhosis Clinician

More information

What Have We Accomplished (and What Lies Ahead)

What Have We Accomplished (and What Lies Ahead) LECTURE What Have We Accomplished (and What Lies Ahead) Roberto de Franchis INTRODUCTION The idea of holding consensus meetings on portal hypertension was born in 1986, when Andrew Burroughs organised

More information

Aspartate aminotransferase-to-platelet ratio index (APRI) for the non-invasive prediction of esophageal varices

Aspartate aminotransferase-to-platelet ratio index (APRI) for the non-invasive prediction of esophageal varices ORIGINAL ARTICLE September-October, Vol. 12 No.5, 2013: 810-814 Aspartate aminotransferase-to-platelet ratio index (APRI) for the non-invasive prediction of esophageal varices Ângelo Zambam de Mattos,*,

More information

Evaluation of liver and spleen stiffness using a ultrasound guided method: Accuracy of ARFI(R) measurements in liver disease patients

Evaluation of liver and spleen stiffness using a ultrasound guided method: Accuracy of ARFI(R) measurements in liver disease patients Evaluation of liver and spleen stiffness using a ultrasound guided method: Accuracy of ARFI(R) measurements in liver disease patients Poster No.: C-3242 Congress: ECR 2010 Type: Topic: Authors: Keywords:

More information

Original Article INTRODUCTION. pissn eissn X

Original Article INTRODUCTION. pissn eissn X pissn 2287-2728 eissn 2287-285X Original Article Clinical and Molecular Hepatology 2016;22:466-476 Emergency endoscopic variceal ligation in cirrhotic patients with blood clots in the stomach but no active

More information

Research Elastography: Liver

Research Elastography: Liver Research Elastography: Liver Giovanna Ferraioli EFSUMB Ultrasound Learning Center Ultrasound Unit - Infectious Diseases Dept. Fondazione IRCCS Policlinico S. Matteo Medical School University of Pavia,

More information

Hepatology For The Nonhepatologist

Hepatology For The Nonhepatologist Hepatology For The Nonhepatologist Andrew Aronsohn, MD Associate Professor of Medicine University of Chicago Chicago, Illinois Learning Objectives After attending this presentation, learners will be able

More information

VIRTUAL UPPER GASTROINTESTINAL ENDOSCOPY

VIRTUAL UPPER GASTROINTESTINAL ENDOSCOPY UnitedHealthcare Oxford Clinical Policy VIRTUAL UPPER GASTROINTESTINAL ENDOSCOPY Policy Number: DIAGNOSTIC 045.9 T2 Effective Date: November 1, 2017 Table of Contents Page INSTRUCTIONS FOR USE... 1 APPLICABLE

More information

Non-Invasive Testing for Liver Fibrosis

Non-Invasive Testing for Liver Fibrosis NORTHWEST AIDS EDUCATION AND TRAINING CENTER Non-Invasive Testing for Liver Fibrosis John Scott, MD, MSc Associate Professor, University of Washington Associate Clinic Director, Hep/Liver Clinic, Harborview

More information

Hemorragia por várices gastroesofágicas en la cirrosis

Hemorragia por várices gastroesofágicas en la cirrosis Hemorragia por várices gastroesofágicas en la cirrosis Referencias 1. Garcia-Tsao G, Sanyal AJ, Grace ND,Carey W, Practice Guidelines Committee of the American Association for the Study of Liver Diseases,

More information

Useful Endoscopic Ultrasonography Parameters and a Predictive Model for the Recurrence of Esophageal Varices and Bleeding after Variceal Ligation

Useful Endoscopic Ultrasonography Parameters and a Predictive Model for the Recurrence of Esophageal Varices and Bleeding after Variceal Ligation Gut and Liver, Vol. 11, No. 6, November 2017, pp. 843-851 ORiginal Article Useful Endoscopic Ultrasonography Parameters and a Predictive Model for the Recurrence of Esophageal Varices and Bleeding after

More information

Original article Correlation between serum-ascites albumin concentration gradient and endoscopic parameters of portal hypertension

Original article Correlation between serum-ascites albumin concentration gradient and endoscopic parameters of portal hypertension Kathmandu University Medical Journal (005), Vol. 3, No., Issue, 37-333 Original article Correlation between serum-ascites albumin concentration gradient and endoscopic parameters of portal hypertension

More information

Practical Approach to Endoscopic Management for Bleeding Gastric Varices

Practical Approach to Endoscopic Management for Bleeding Gastric Varices Review Article http://dx.doi.org/10.3348/kjr.2012.13.s1.s40 pissn 1229-6929 eissn 2005-8330 Korean J Radiol 2012;13(S1):S40-S44 Practical Approach to Endoscopic Management for Bleeding Gastric Varices

More information

Serag Esmat 1 and Dalia Omran 2

Serag Esmat 1 and Dalia Omran 2 Study of the Right Liver Lobe Size /Albumin Ratio as a Noninvasive Predictor of Oesophageal Varices Compared to: Spleen Size, Platelet Count and Platelet Count/Spleen Diameter Ratio in Post Hepatitis C

More information

BETA-BLOCKERS IN CIRRHOSIS.PRO.

BETA-BLOCKERS IN CIRRHOSIS.PRO. BETA-BLOCKERS IN CIRRHOSIS.PRO. Angela Puente Sánchez. MD PhD Hepatology Unit. Gastroenterology department Marques de Valdecilla University Hospital. Santander INTRODUCTION. Natural history of cirrhosis

More information

Original Article PLATELET COUNT TO SPLEEN DIAMETER RATIO AS A PREDICTOR OF ESOPHAGEAL VARICES IN PATIENTS OF LIVER CIRRHOSIS DUE TO HEPATITIS C VIRUS

Original Article PLATELET COUNT TO SPLEEN DIAMETER RATIO AS A PREDICTOR OF ESOPHAGEAL VARICES IN PATIENTS OF LIVER CIRRHOSIS DUE TO HEPATITIS C VIRUS Original Article AS A PREDICTOR OF ESOPHAGEAL VARICES IN PATIENTS OF LIVER CIRRHOSIS DUE TO HEPATITIS C VIRUS Khalid Amin 1, Dilshad Muhammad 2, Amin Anjum 3, Kashif Jamil 4, Ali Hassan 5 1 Associate Professor

More information

Correlation of serum-ascites albumin concentration gradient and endoscopic parameters of portal hypertension in chronic liver disease

Correlation of serum-ascites albumin concentration gradient and endoscopic parameters of portal hypertension in chronic liver disease International Journal of Advances in Medicine Suresh I et al. Int J Adv Med. 2018 Feb;5(1):159-163 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20180077

More information

VIRTUAL UPPER GASTROINTESTINAL ENDOSCOPY

VIRTUAL UPPER GASTROINTESTINAL ENDOSCOPY MEDICAL POLICY VIRTUAL UPPER GASTROINTESTINAL ENDOSCOPY Policy Number: 2013T0400H Effective Date: October 1, 2013 Table of Contents COVERAGE RATIONALE... BACKGROUND... CLINICAL EVIDENCE... U.S. FOOD AND

More information

GI bleeding in chronic liver disease

GI bleeding in chronic liver disease GI bleeding in chronic liver disease Stuart McPherson Consultant Hepatologist Liver Unit, Freeman Hospital, Newcastle upon Tyne and Institute of Cellular Medicine, Newcastle University. Case 54 year old

More information

Evaluation of liver and spleen stiffness using a ultrasound guided method: Accuracy of ARFI(R) measurements in liver disease patients

Evaluation of liver and spleen stiffness using a ultrasound guided method: Accuracy of ARFI(R) measurements in liver disease patients Evaluation of liver and spleen stiffness using a ultrasound guided method: Accuracy of ARFI(R) measurements in liver disease patients Poster No.: C-3242 Congress: ECR 2010 Type: Topic: Authors: Keywords:

More information

Learning Objectives. After attending this presentation, participants will be able to:

Learning Objectives. After attending this presentation, participants will be able to: Learning Objectives After attending this presentation, participants will be able to: Describe HCV in 2015 Describe how to diagnose advanced liver disease and cirrhosis Identify the clinical presentation

More information

VIRTUAL UPPER GASTROINTESTINAL ENDOSCOPY

VIRTUAL UPPER GASTROINTESTINAL ENDOSCOPY UnitedHealthcare Commercial Medical Policy VIRTUAL UPPER GASTROINTESTINAL ENDOSCOPY Policy Number: GAS018 Effective Date: December 1, 2017 Table of Contents Page INSTRUCTIONS FOR USE... 1 BENEFIT CONSIDERATIONS...

More information

LIVER, PANCREAS, AND BILIARY TRACT

LIVER, PANCREAS, AND BILIARY TRACT CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2012;10:1028 1033 LIVER, PANCREAS, AND BILIARY TRACT Prevalence and Indicators of Portal Hypertension in Patients With Nonalcoholic Fatty Liver Disease FLAVIA D.

More information

Ultrasound assessment of coronary veins as non-invasive marker for esophageal varices

Ultrasound assessment of coronary veins as non-invasive marker for esophageal varices Ultrasound assessment of coronary veins as non-invasive marker for esophageal varices Poster No.: C-1657 Congress: ECR 2011 Type: Scientific Exhibit Authors: R. Castellón Siles, A. Thomas, X. Serres, O.

More information

Clinical Trials & Endpoints in NASH Cirrhosis

Clinical Trials & Endpoints in NASH Cirrhosis Clinical Trials & Endpoints in NASH Cirrhosis April 25, 2018 Peter G. Traber, MD CEO & CMO, Galectin Therapeutics 2018 Galectin Therapeutics NASDAQ: GALT For more information, see galectintherapeutics.com

More information

Carvedilol or Propranolol in the Management of Portal Hypertension?

Carvedilol or Propranolol in the Management of Portal Hypertension? Evidence Based Case Report Carvedilol or Propranolol in the Management of Portal Hypertension? Arranged by: dr. Saskia Aziza Nursyirwan RESIDENCY PROGRAM OF INTERNAL MEDICINE DEPARTMENT UNIVERSITY OF INDONESIA

More information

Alice Fung, MD Oregon Health and Science University

Alice Fung, MD Oregon Health and Science University Alice Fung, MD Oregon Health and Science University Disclosure Comments The speaker Alice Fung, MD Has relevant financial relationships to disclose. Received honorarium from (Guerbet). This individual

More information

Invasive Evaluation of Portal Hypertension. Vincenzo La Mura, MD PhD Department of Biomedical Sciences for Health University of Milan

Invasive Evaluation of Portal Hypertension. Vincenzo La Mura, MD PhD Department of Biomedical Sciences for Health University of Milan Invasive Evaluation of Portal Hypertension Vincenzo La Mura, MD PhD Department of Biomedical Sciences for Health University of Milan Vincenzo La Mura, MD, PhD Dipartimento di scienze Biomediche per la

More information

P ortal hypertension commonly accompanies the presence

P ortal hypertension commonly accompanies the presence 1200 LIVER Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis E Giannini, F Botta,

More information

Upper Gastrointestinal Bleeding Score for Differentiating Variceal and Nonvariceal Upper Gastrointestinal Bleeding ABSTRACT

Upper Gastrointestinal Bleeding Score for Differentiating Variceal and Nonvariceal Upper Gastrointestinal Bleeding ABSTRACT 44 Original Article Upper Gastrointestinal Bleeding Score for Differentiating Variceal and Jaroon Chasawat Varayu Prachayakul Supot Pongprasobchai ABSTRACT Background: Upper gastrointestinal bleeding (UGIB)

More information

Surveillance for Hepatocellular Carcinoma

Surveillance for Hepatocellular Carcinoma Surveillance for Hepatocellular Carcinoma Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded on April

More information

Radiation burden of hepatocellular carcinoma screening program in hepatitis B virus patients should we recommend magnetic resonance imaging instead?

Radiation burden of hepatocellular carcinoma screening program in hepatitis B virus patients should we recommend magnetic resonance imaging instead? Radiation burden of hepatocellular carcinoma program in hepatitis B virus patients should we recommend magnetic resonance imaging instead? Background: Current Hepatocellular Carcinoma (HCC) surveillance

More information

Journal of the Egyptian Society of Parasitology, Vol.45, No.3, December 2015 J. Egypt. Soc. Parasitol. (JESP), 45(3), 2015:

Journal of the Egyptian Society of Parasitology, Vol.45, No.3, December 2015 J. Egypt. Soc. Parasitol. (JESP), 45(3), 2015: Journal of the Egyptian Society of Parasitology, Vol.45, No.3, December 2015 J. Egypt. Soc. Parasitol. (JESP), 45(3), 2015: 485-492 PLATELET COUNT TO SPLEEN DIAMETER RATIO AND TO SPLEEN AREA RATIO AS PREDICTORS

More information

Module 1 Introduction of hepatitis

Module 1 Introduction of hepatitis Module 1 Introduction of hepatitis 1 Training Objectives At the end of the module, trainees will be able to ; Demonstrate improved knowledge of the global epidemiology of the viral hepatitis Understand

More information

NONSELECTIVE BETA-BLOCKERS IN PATIENTS WITH CIRRHOSIS: THE THERAPEUTIC WINDOW

NONSELECTIVE BETA-BLOCKERS IN PATIENTS WITH CIRRHOSIS: THE THERAPEUTIC WINDOW Rev. Med. Chir. Soc. Med. Nat., Iaşi 2016 vol. 120, no. 1 INTERNAL MEDICINE UPDATES NONSELECTIVE BETA-BLOCKERS IN PATIENTS WITH CIRRHOSIS: THE THERAPEUTIC WINDOW Mihaela Dimache 1,2*, Irina Gîrleanu 1,2,

More information

Changes in the Clinical Outcomes of Variceal Bleeding in Cirrhotic Patients: A 10-Year Experience in Gangwon Province, South Korea

Changes in the Clinical Outcomes of Variceal Bleeding in Cirrhotic Patients: A 10-Year Experience in Gangwon Province, South Korea Gut and Liver, Vol. 6, No. 4, October 2012, pp. 476481 ORiginal Article Changes in the Clinical Outcomes of Variceal Bleeding in Cirrhotic Patients: A 10Year Experience in Gangwon Province, South Korea

More information

Original papers Med Ultrason 2013, Vol. 15, no. 2, Ioan Sporea, Iulia Raţiu, Simona Bota, Roxana Şirli, Ana Jurchiş

Original papers Med Ultrason 2013, Vol. 15, no. 2, Ioan Sporea, Iulia Raţiu, Simona Bota, Roxana Şirli, Ana Jurchiş Original papers Med Ultrason 2013, Vol. 15, no. 2, 111-115 DOI: 10.11152/mu.2013.2066.152.is1ir2 Are different cut-off values of liver stiffness assessed by Transient Elastography according to the etiology

More information

Doppler Surrogate Endoscopy for Screening Esophageal Varices in Patients With Cirrhosis

Doppler Surrogate Endoscopy for Screening Esophageal Varices in Patients With Cirrhosis Hepat Mon. 2014 January; 14(1): e11237. Published online 2014 January 16. DOI: 10.5812/hepatmon.11237 Research Article Doppler Surrogate Endoscopy for Screening Esophageal Varices in Patients With Cirrhosis

More information

HCC and mass effect. Hepatocellular cancer: what if the AFP is rising but no lesion seen on imaging? What you need to know about AFP.

HCC and mass effect. Hepatocellular cancer: what if the AFP is rising but no lesion seen on imaging? What you need to know about AFP. Hepatocellular cancer: what if the AFP is rising but no lesion seen on imaging? Arun J Sanyal M.B.B.S., M.D. Charles Caravati Professor of Medicine Virginia Commonwealth University Imaging features used

More information

New York State HCV Provider Webinar Series

New York State HCV Provider Webinar Series New York State HCV Provider Webinar Series Overview of Fibrosis-Staging, Child s Pugh, MELD Scores Paul J Gaglio, MD, FACP, AGAF, FAASLD Director: Hepatology Outreach Professor of Medicine (in Surgery)

More information

Innovations in HCC Imaging: MDCT/MRI

Innovations in HCC Imaging: MDCT/MRI Innovations in HCC Imaging: MDCT/MRI Anthony E. Cheng, M.D. Cardinal MRI Center Cardinal Santos Medical Center, Wilson Street, San Juan Innovations in HCC Imaging: Goals/Objectives MDCT/MRI Learn the diagnostic

More information

DISCLOSURES. This activity is jointly provided by Northwest Portland Area Indian Health Board and Cardea

DISCLOSURES. This activity is jointly provided by Northwest Portland Area Indian Health Board and Cardea DISCLOSURES This activity is jointly provided by Northwest Portland Area Indian Health Board and Cardea Cardea Services is approved as a provider of continuing nursing education by Montana Nurses Association,

More information

LIVER CIRRHOSIS. The liver extracts nutrients from the blood and processes them for later use.

LIVER CIRRHOSIS. The liver extracts nutrients from the blood and processes them for later use. LIVER CIRRHOSIS William Sanchez, M.D. & Jayant A. Talwalkar, M.D., M.P.H. Advanced Liver Disease Study Group Miles and Shirley Fiterman Center for Digestive Diseases Mayo College of Medicine Rochester,

More information

Review Article Self-Expandable Metal Stents in the Treatment of Acute Esophageal Variceal Bleeding

Review Article Self-Expandable Metal Stents in the Treatment of Acute Esophageal Variceal Bleeding Hindawi Publishing Corporation Gastroenterology Research and Practice Volume 2011, Article ID 910986, 6 pages doi:10.1155/2011/910986 Review Article Self-Expandable Metal Stents in the Treatment of Acute

More information

GIQIC18 Appropriate follow-up interval of not less than 5 years for colonoscopies with findings of 1-2 tubular adenomas < 10 mm

GIQIC18 Appropriate follow-up interval of not less than 5 years for colonoscopies with findings of 1-2 tubular adenomas < 10 mm GI Quality Improvement Consortium, Ltd. (GIQuIC) 1 Following is an overview of the clinical quality measures in GIQuIC that can be reported to CMS for the Quality performance category of the Merit-Based

More information

Transfusion strategies in patients with cirrhosis: less is more. 1. Department of Gastroenterology, Hillingdon Hospital, London, UK

Transfusion strategies in patients with cirrhosis: less is more. 1. Department of Gastroenterology, Hillingdon Hospital, London, UK Transfusion strategies in patients with cirrhosis: less is more Evangelia M. Fatourou 1, Emmanuel A. Tsochatzis 2 1. Department of Gastroenterology, Hillingdon Hospital, London, UK 2. UCL Institute for

More information

Cases: Treatment of Hepatitis C in Patients with Cirrhosis and Advanced Liver Disease

Cases: Treatment of Hepatitis C in Patients with Cirrhosis and Advanced Liver Disease Slide 1 of 20 Cases: Treatment of Hepatitis C in Patients with Cirrhosis and Advanced Liver Disease Kenneth E. Sherman, MD, PhD Gould Professor of Medicine Director, Division of Digestive Diseases University

More information

ACG Clinical Guideline: Diagnosis and Management of Small Bowel Bleeding

ACG Clinical Guideline: Diagnosis and Management of Small Bowel Bleeding ACG Clinical Guideline: Diagnosis and Management of Small Bowel Bleeding Lauren B. Gerson, MD, MSc, FACG 1, Jeff L. Fidler 2, MD, David R. Cave, MD, PhD, FACG 3, Jonathan A. Leighton, MD, FACG 4 1 Division

More information

DISEASE LEVEL MEDICAL EVIDENCE PROTOCOL

DISEASE LEVEL MEDICAL EVIDENCE PROTOCOL DISEASE LEVEL MEDICAL EVIDENCE PROTOCOL 1. This Protocol sets out the medical evidence that must be delivered to the Administrator for proof of Disease Level. It is subject to such further and other Protocols

More information

Hepatocellular Carcinoma. Markus Heim Basel

Hepatocellular Carcinoma. Markus Heim Basel Hepatocellular Carcinoma Markus Heim Basel Outline 1. Epidemiology 2. Surveillance 3. (Diagnosis) 4. Staging 5. Treatment Epidemiology of HCC Worldwide, liver cancer is the sixth most common cancer (749

More information

WHEN HCV TREATMENT IS DEFERRED WV HEPC ECHO PROJECT

WHEN HCV TREATMENT IS DEFERRED WV HEPC ECHO PROJECT WHEN HCV TREATMENT IS DEFERRED WV HEPC ECHO PROJECT October 13, 2016 Reminder - treatment is recommended for all patients with chronic HCV infection Except short life expectancies that cannot be remediated

More information

Validation of Clinical Outcomes in Electronic Data Sources

Validation of Clinical Outcomes in Electronic Data Sources Validation of Clinical Outcomes in Electronic Data Sources Vincent Lo Re, MD, MSCE Assistant Professor of Medicine and Epidemiology Center for Clinical Epidemiology and Biostatistics Center for Pharmacoepidemiology

More information

Cirrhosis and Portal Hypertension Gastroenterology Teaching Project American Gastroenterological Association

Cirrhosis and Portal Hypertension Gastroenterology Teaching Project American Gastroenterological Association CIRRHOSIS AND PORTAL HYPERTENSION Cirrhosis and Portal Hypertension Gastroenterology Teaching Project American Gastroenterological Association WHAT IS CIRRHOSIS? What is Cirrhosis? DEFINITION OF CIRRHOSIS

More information

Are extra-colonic findings on CT colonogram clinically significant? A review of 758 consecutive cases

Are extra-colonic findings on CT colonogram clinically significant? A review of 758 consecutive cases Are extra-colonic findings on CT colonogram clinically significant? A review of 758 consecutive cases Lynn WR 1, Vadhwana B 1, Borgstein R 2, Demetriou G 1, Nair MS 1, Meleagros L 1, Bell DJ 2 1 Department

More information

Journal of American Science 2014;10(10)

Journal of American Science 2014;10(10) Platelet Count/Spleen Diameter Ratio, as a Non-Invasive Diagnosis of Esophageal Varices in Egyptian Patients with Liver Cirrhosis Khaled El-Mola 1,Hesham Alshabrawy 3, Mohamed Salah 2,and Al sayed M.Rashed

More information

VARICEAL BLEEDING. Ram Subramanian MD Hepatology & Critical Care Medical Director of Liver Transplant Emory University, Atlanta.

VARICEAL BLEEDING. Ram Subramanian MD Hepatology & Critical Care Medical Director of Liver Transplant Emory University, Atlanta. VARICEAL BLEEDING Ram Subramanian MD Hepatology & Critical Care Medical Director of Liver Transplant Emory University, Atlanta Disclosures: None OUTLINE Pathophysiology of portal hypertension Splanchnic

More information

Portal Venous Thrombosis: Tumor VS Bland Thrombus

Portal Venous Thrombosis: Tumor VS Bland Thrombus June 2015 Portal Venous Thrombosis: Tumor VS Bland Thrombus SERGIO ALFARO, HARVARD MEDICAL SCHOOL YEAR III GILLIAN LIEBERMAN, MD Overview 2 Index Patient History Portal Venous Thrombosis (PVT) Imaging

More information

Diagnosi e management non invasivo dell epatite cronica da HCV

Diagnosi e management non invasivo dell epatite cronica da HCV Diagnosi e management non invasivo dell epatite cronica da HCV Giovanni Squadrito Clinical and Molecular Hepatology University of Messina gsquadrito@unime.it Outline Diagnosis of HCV Non invasive tools

More information

Contrast Enhanced Ultrasound of Parenchymal Masses in Children

Contrast Enhanced Ultrasound of Parenchymal Masses in Children Contrast Enhanced Ultrasound of Parenchymal Masses in Children Sue C Kaste, DO On behalf of Beth McCarville, MD St. Jude Children s Research Hospital Memphis, TN Overview Share St. Jude experience with

More information

Steps in Assessing Fibrosis 4/30/2015. Overview of Liver Disease Associated With HCV

Steps in Assessing Fibrosis 4/30/2015. Overview of Liver Disease Associated With HCV Overview of Liver Disease Associated With HCV Marion G. Peters, MD John V. Carbone, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco San Francisco,

More information

Case Report: Refractory variceal bleeding Christophe Hézode, Henri Mondor Hospital, Paris-Est University, Créteil, France

Case Report: Refractory variceal bleeding Christophe Hézode, Henri Mondor Hospital, Paris-Est University, Créteil, France Case Report: Refractory variceal bleeding Christophe Hézode, Henri Mondor Hospital, Paris-Est University, Créteil, France Thank you to Marika Rudler, Dominique Thabut, Adrian Gadano, and Jaime Bosch for

More information

Sandipan Ghose, Md. Azizul Hoque, Md. Khalilur Rahman, Mohd. Harun-or-Rashid

Sandipan Ghose, Md. Azizul Hoque, Md. Khalilur Rahman, Mohd. Harun-or-Rashid Sandipan Ghose, Md. Azizul Hoque, Md. Khalilur Rahman, Mohd. Harun-or-Rashid Liver cirrhosis may be defined as a diffuse process characterized by fibrosis and conversion of normal liver architecture into

More information

Hepatitis Alert: Management of Patients With HCV Who Have Achieved SVR

Hepatitis Alert: Management of Patients With HCV Who Have Achieved SVR Hepatitis Alert: Management of Patients With HCV Who Have Achieved SVR This program is supported by educational grants from AbbVie, Gilead Sciences, and Merck About These Slides Please feel free to use,

More information

Portal Hypertension in Patients with Liver Cirrhosis: Diagnostic Accuracy of Spleen Stiffness 1

Portal Hypertension in Patients with Liver Cirrhosis: Diagnostic Accuracy of Spleen Stiffness 1 This copy is for personal use only. To order printed copies, contact reprints@rsna.org Yoshitaka Takuma, MD Kazuhiro Nouso, MD Youichi Morimoto, MD Junko Tomokuni, BA Akiko Sahara, BA Hiroyuki Takabatake,

More information

LIVER IMAGING TIPS IN VARIOUS MODALITIES. M.Vlychou, MD, PhD Assoc. Professor of Radiology University of Thessaly

LIVER IMAGING TIPS IN VARIOUS MODALITIES. M.Vlychou, MD, PhD Assoc. Professor of Radiology University of Thessaly LIVER IMAGING TIPS IN VARIOUS MODALITIES M.Vlychou, MD, PhD Assoc. Professor of Radiology University of Thessaly Hepatocellular carcinoma is a common malignancy for which prevention, screening, diagnosis,

More information

The Focal Hepatic Lesion: Radiologic Assessment

The Focal Hepatic Lesion: Radiologic Assessment The Focal Hepatic Lesion: Radiologic Assessment Kevin Kuo, Harvard Medical School Year III Our Patient: PS 67 y/o female w/ long history of alcohol use Drinking since age 18, up to one bottle of wine/day

More information

Virtual Mentor American Medical Association Journal of Ethics December 2008, Volume 10, Number 12:

Virtual Mentor American Medical Association Journal of Ethics December 2008, Volume 10, Number 12: Virtual Mentor American Medical Association Journal of Ethics December 2008, Volume 10, Number 12: 805-809. CLINICAL PEARL Indications for Use of TIPS in Treating Portal Hypertension Elizabeth C. Verna,

More information

Digestive and Liver Disease

Digestive and Liver Disease Digestive and Liver Disease 43 (2011) 48 53 Contents lists available at ScienceDirect Digestive and Liver Disease journal homepage: www.elsevier.com/locate/dld Digestive endoscopy Oesophagogastroduodenoscopy

More information

Quantitative Assessment of the Liver: Breath Tests. M. Shadab Siddiqui, M.D. Virginia Commonwealth University

Quantitative Assessment of the Liver: Breath Tests. M. Shadab Siddiqui, M.D. Virginia Commonwealth University Quantitative Assessment of the Liver: Breath Tests M. Shadab Siddiqui, M.D. Virginia Commonwealth University Objectives Principles of breath tests Breath tests in NAFLD Potential applications of breath

More information

Thrombocytopenia and Chronic Liver Disease

Thrombocytopenia and Chronic Liver Disease Thrombocytopenia and Chronic Liver Disease Severe thrombocytopenia (platelet count

More information

Hepatocellular Carcinoma: Diagnosis and Management

Hepatocellular Carcinoma: Diagnosis and Management Hepatocellular Carcinoma: Diagnosis and Management Nizar A. Mukhtar, MD Co-director, SMC Liver Tumor Board April 30, 2016 1 Objectives Review screening/surveillance guidelines Discuss diagnostic algorithm

More information

Matching study design to research question-interactive learning session

Matching study design to research question-interactive learning session Matching study design to research question-interactive learning session Rahul Mhaskar Assistant Professor Clinical and Translational Science Institute Division and Center for Evidence based Medicine and

More information

June By: Reza Gholami

June By: Reza Gholami ACG/CAG guideline on Management of Dyspepsia June 2017 By: Reza Gholami DEFINITION OF DYSPEPSIA AND SCOPE OF THE GUIDELINE Dyspepsia was originally defined as any symptoms referable to the upper gastrointestinal

More information

Management. Chapter 11. Primary Author. Contributing Authors. University of Toronto & University of Ottawa. Illustrators & figure contributors

Management. Chapter 11. Primary Author. Contributing Authors. University of Toronto & University of Ottawa. Illustrators & figure contributors Chapter 11 Primary Author Donald G. Mitchell Thomas Jefferson University Contributing Authors Victoria Chernyak Ania Z. Kielar Yuko Kono Claude B. Sirlin Montefiore Medical Center University of Toronto

More information

HEPATOCELLULAR CARCINOMA: AN OVERVIEW

HEPATOCELLULAR CARCINOMA: AN OVERVIEW HEPATOCELLULAR CARCINOMA: AN OVERVIEW John K. Olynyk Head, Department of Gastroenterology & Hepatology Fiona Stanley Fremantle Hospital Group Dean of Research, Edith Cowan University RISING MORTALITY OF

More information

ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts

ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts Grace H. Elta, MD, FACG 1, Brintha K. Enestvedt, MD, MBA 2, Bryan G. Sauer, MD, MSc, FACG (GRADE Methodologist) 3 and Anne Marie Lennon,

More information